Skip to main content
Clinical Trials/NCT06554119
NCT06554119RecruitingNot Applicable

Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University

Guangdong Provincial People's Hospital1 site in 1 country375 target enrollmentStarted: January 1999Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Recruiting
Enrollment
375
Locations
1
Primary Endpoint
death rate

Study Overview

Brief Summary

This study aims to present our center's experience in managing postoperative tricuspid valve regurgitation over the past 25years and to analyze the outcomes of these surgical treatments.

Study Design

Study Type
Observational
Observational Model
Cohort
Time Perspective
Retrospective

Eligibility Criteria

Ages
16 Years to — (Child, Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • patients who underwent surgical treatment from 1999 to 2023 for tricuspid valve disease following cardiac surgery

Exclusion Criteria

  • age <16,severe tricuspid regurgitation secondary to primary pulmonary hypertension, and those with substantial missing case data.

Outcomes

Primary Outcomes

death rate

Time Frame: 1999-01 - 2025-01

perioperative and longterm

complications

Time Frame: 1999-01 - 2025-01

perioperative and longterm complications

Secondary Outcomes

  • redo of tricuspid valve(1999-01 - 2025-01)

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Huanlei Huang, PhD

MD. pHD

Guangdong Provincial People's Hospital

Study Sites (1)

Loading locations...

Similar Trials